Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC) Heng, D., Rini, B. I., Lee, J., Kroeger, N., Srinivas, S., Harshman, L., Knox, J. J., Bjarnason, G. A., MacKenzie, M. J., Wood, L., Vaishampayan, U. N., Agarwal, N., Pal, S., Tan, M., Rha, S., Yuasa, T., Donskov, F., Bamias, A., North, S. A., Choueiri, T. K. AMER SOC CLINICAL ONCOLOGY. 2013
View details for Web of Science ID 000335419601600